1、Yang Xiangdong, et.al. Upregulation of TIPE1 in tubular epithelial cell aggravates diabetic nephropathy by disrupting PHB2 mediated mitophagy. Redox Biol. 2022 04 ;50:102260.
2. Yang Xiangdong, et.al. Tim-3 aggravates podocyte injury in diabetic nephropathy by promoting macrophage activation via the NF-κB/TNF-α pathway. Molecular Metabolism. 2019.23:24-36.
3.Yang Xiangdong, et.al. IDO1 as a new immune biomarker for diabetic nephropathy and its correlation with immune cell infiltration. Int Immunopharmacol.2021.94:107446
4.Yang Xiangdong, et.al. APOC1 exacerbates renal fibrosis through the activation of the NF-κB signaling pathway in IgAN. Front Pharmacol. 2023 May 25;14:1181435.
5.Yang Xiangdong, et.al. APOC1 as a novel diagnostic biomarker for DN based on machine learning algorithms and experiment. Front Endocrinol (Lausanne). 2023 Feb 20;14:1102634.
6.Yang Xiangdong, et.al. Analysis of clinical features and pathology of serum HBsAg positive glomerulonephritis. J Med Virol. 2018 Mar;90(3):612-615.
7.Yang Xiangdong, et.al. Apigenin suppresses mouse peritoneal fibrosis by down-regulating miR34a expression. Biomed Pharmacother. 2018 Oct;106:373-380.
8.Yang Xiangdong, et.al. Short term ex vivo storage of kidneys cause progressive nuclear ploidy changes of renal tubular epitheliocytes. Scientific reports. 2015,5.
9.Yang Xiangdong, et.al. Pentraxin-3 Attenuates Renal Damage in Diabetic Nephropathy by Promoting M2 Macrophage Differentiation. Inflammation. 2015,38(5).
10.Yang Xiangdong, et.al. Expression of human T cell immunoglobulin domain and mucin-3 on kidney tissue from immunoglobulin A nephropathy patients. Immunol Res. 2014 Oct;60(1):85-90.